期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

乳腺癌内分泌治疗的基本药物和新动向 被引量：4

下载PDF
导出
摘要 乳腺癌的发生、发展与患者体内雌激素密切相关，自1896年Beatson首次使用卵巢切除术治疗晚期乳腺癌以来，内分泌治疗在乳腺癌综合治疗中的地位越来越重要，目前大家已逐渐认识内分泌治疗与化疗是乳腺癌药物治疗的“左膀右臂”。
作者 宋三秦 张少华
机构地区 军事医学科学院附属医院乳腺肿瘤科
出处 《实用肿瘤学杂志》 CAS 2010年第4期301-304,336,共5页 Practical Oncology Journal
关键词 乳腺癌 内分泌治疗 化学治疗
分类号 R730.53 [医药卫生—肿瘤] R737.9 [医药卫生—肿瘤]
  • 相关文献

参考文献21

  • 1Buzdar A,Douma J,Davidson N,et al.Phase III,multicenter,double blind,randomized study of letrozole,an aromatase inhibitor,for advanced breast cancer versus megestrol acetate[J].J Clin Oncol.2001,19(23):3357-3366.
  • 2Buzdar AU,Jonat W,Howell A,et al.Anastrozole versus megestrol acetate in the treatment of postmenopausal women with advanced breast carcinoma:results of a survival update based on a combined analysis of data from two mature phase III trials.Arimidex Study Group[J].Cancer.1998,83(6):1142-1152.
  • 3Bonneter re J,Thurlimann B,Robertson JF,et al.Anastrozole versus tamoxifen as first-line therapy for advanced breast cancer in 668 postmenopausal women:results of the Tamoxifen or Arimidex Randomized Group Efficacy and Tolerability study[J].J Clin Oncol.2000,18(22):3748-3757.
  • 4Nabholtz JM,Buzdar A,Pollak M,et al.Anastrozole is superior to tamoxifen as first-line therapy for advanced breast cancer in postmenopausal women:results of a North American multicenter randomized trial.Arimidex Study Group[J].J Clin Oncol.2000,18(22):3758-3767.
  • 5Vergote I,Bonneterre J,Thurlimann B,et al.Randomised study of anastrozole versus tamoxifen as first-line therapy for advanced breast cancer in postmenopausal women[J].Eur J Cancer.2000,36(suppl 4):84-85.
  • 6Chia S,Gradishar W,Mauriac L,et al.Double-blind,randomized placebo controlled trial of fulvestrant compared with exemestane after priornonsteroidal aromatase inhibitor therapy in postmenopausal women with hormone receptor-positive,advanced breast cancer:results from EFECT[J].J Clin Oncol.2008,26(10):1664-1670.
  • 7Ellis MJ,Ma C.Letrozole in the neoadjuvant setting:the P024 trial[J].Breast Cancer Res Treat.2007,105(Suppl 1):33-43.
  • 8Early Breast Cancer Trialists' Collaborative Group.Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival:an overview of the randomised trials[J].Lancet.2005,365(9472):1687-1717.
  • 9Fisher B,Dignam J,Bryant J,et al.Five versus more than five years of tamoxifen for lymph node-negative breast cancer:updated findings from the National Surgical Adjuvant Breast and Bowel Project B-14 randomized trial[J].J Natl Cancer Inst.2001,93(9):684-90.
  • 10Burdette-Radoux S,Muss HB.A question of duration:do patients with early-stage breast cancer need more than five years of adjuvant endocrine therapy[J].Clin Breast Cancer.2009,9(Suppl 1):S37-41.

同被引文献25

  • 1孙萍,于雁.循环系统肿瘤细胞检测的进展[J].实用肿瘤学杂志,2004,18(6):472-474. 被引量：2
  • 2Lonning PE, Taylor PD, Anker G, et al. High - dose estrogen treatment in post - menopausal breast cancer patients heavi- ly exposed to endocrine therapy [ J ]. Breast Cancer ResTreat,2001,67(2) :111 - 116.
  • 3Ellis M J, Dehdahti F, Kommareddy A, et al. A randomized phase 2 trial of low dose ( 6 mg daily) versus high dose ( 30 mg daily)estradiol for patients with estrogen receptor posi- tive aromatase inhibitor resistant advanced breast cancer [ J ]. Cancer Res,2009,302 (7) :774 - 780.
  • 4Shu Zhao, Qingyuan Zhang. The prognostic role of circulat- ing tumor cells ( CTCs ) detected by RT - PCR in breast cancer: a meta - analysis of published hterature [ J ]. Breast Cancer Res Treat,2011,130 ( 3 ) : 809 - 816.
  • 5Pachmann K, Camara O, Kavallaris A, et al. Monitoring the response of circulating epithelial tumor cells to adjuvant chemotherapy in breast cancer allows detection of patients at risk of early relapse[ J]. Clin Oncol,2008,26 (8):1208 - 2015.
  • 6Mitra Tewes, Bahfiye Aktas, Anja Welt, et al. Molecular pro- filing and predictive value of circulating tumor ceils in pa- tients with metastatic breast cancer:an option for monitoring response to breast cancer related therapies[ J ]. Breast Canc- er Res Treat,2009,115 ( 3 ) :581 - 590.
  • 7Serrano M J, S6nchez - Rovira P, Delgado - Rodriguez M, et al. Detection of circulating tumor cells in the context of treatment:Prognostic value in breast cancer[ J ]. Cancer Biol Ther,2009,8 ( 8 ) :671 - 675.
  • 8Dorssers LC,Van der Flier S,Brinkman A,et al. Tamoxifenresistance in breast cancer elucidating mechanisms [ J ].Drugs,2001,61 (12) ; 1721 - 1733.
  • 9Van Agthoven T, Sieuwerts AM, Meijer - van Gelder ME,etin human breast cancer progression and tamoxifen resistance[j]. J Clin Oncol, 2009,27 (4) : 542-549.
  • 10McClelland RA t Barrow D, Madden T,et al. Enhanced epi-dermal growth factor receptor signaling in MCF7 breastcancer cells after long - term culture in the presence of thepure antiestrogen ICI 182 ,780( Faslodex) [ J]. Endocrinolo-gy,2001,142(68) :2776 -2788.

引证文献4

二级引证文献16

实用肿瘤学杂志
2010年 第4期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部